Carl N Valentine1, Roberto Barresi, Richard A Prinz. 1. Department of General Surgery, 785 Jelke Building, Rush-Presbyterian-St. Luke's Medical Center, 1653 W. Congress Parkway, Chicago, IL 60612, USA.
Abstract
BACKGROUND: Reoperation for recurrent thyroid cancer poses an increased risk of complications, including thoracic duct fistula. Treatment of this complication is controversial. A survey of thoracic literature reports the use of somatostatin analog, whereas no cases have reported the use of this therapy in cases arising from neck dissection. METHODS: We report a 16-year-old girl with recurrent papillary thyroid cancer who had a persistent lymphatic-cutaneous fistula develop after repeat modified left neck dissection. Despite conservative management, drainage persisted for 2 months. A regimen was begun that included TPN and injections of a somatostatin analog. RESULTS: Treatment with a somatostatin analog resulted in an immediate attenuation of drainage and subsequent closure of the fistula after 16 days of treatment. CONCLUSION: The use of somatostatin analog can increase the success of conservative management of thoracic duct fistulae. Copyright 2002 Wiley Periodicals, Inc.
BACKGROUND: Reoperation for recurrent thyroid cancer poses an increased risk of complications, including thoracic duct fistula. Treatment of this complication is controversial. A survey of thoracic literature reports the use of somatostatin analog, whereas no cases have reported the use of this therapy in cases arising from neck dissection. METHODS: We report a 16-year-old girl with recurrent papillary thyroid cancer who had a persistent lymphatic-cutaneous fistula develop after repeat modified left neck dissection. Despite conservative management, drainage persisted for 2 months. A regimen was begun that included TPN and injections of a somatostatin analog. RESULTS: Treatment with a somatostatin analog resulted in an immediate attenuation of drainage and subsequent closure of the fistula after 16 days of treatment. CONCLUSION: The use of somatostatin analog can increase the success of conservative management of thoracic duct fistulae. Copyright 2002 Wiley Periodicals, Inc.
Authors: Ali Harlak; Serdar Karahatay; Onder Onguru; Oner Mentes; Mustafa Gerek; Turgut Tufan Journal: Breast Care (Basel) Date: 2008-08-11 Impact factor: 2.860
Authors: Yong Sang Lee; Kee-Hyun Nam; Woong Youn Chung; Hang-Seok Chang; Cheong Soo Park Journal: J Korean Med Sci Date: 2010-03-19 Impact factor: 2.153